A shocking revelation has emerged from a recent investigation, uncovering potential risks in 209 cases within the North Kerry Child and Adolescent Mental Health Services (CAMHS). This independent review, commissioned by the Health Service Executive, sheds light on a concerning situation.
The severity of the risks: Out of the 209 cases, the report classified 195 as moderate risk, a staggering number that raises questions about the quality of care. But here's where it gets controversial—two cases were deemed to have a major risk, and 12 were considered minor. This distribution of risks is a cause for alarm and prompts further scrutiny.
The review examined 374 active cases on the CAMHS database in November 2022, revealing a series of issues. One notable finding was the high rate of antipsychotic medication prescriptions, which is a significant concern for such a young demographic. Additionally, the service fell short in conducting recommended physical health assessments and monitoring, a fundamental aspect of patient care. The report also highlights a low rate of individual or family psychotherapeutic interventions, which are crucial for holistic treatment.
Controversial Practices: The absence of standard operating procedures is a startling revelation, leaving room for inconsistent and potentially unsafe practices. The review, led by Dr. Colette Halpin, a consultant child and adolescent psychiatrist, found that 79% of patients attending the generic service were prescribed psychotropic medication, a stark contrast to the HSE National Audit's figure of 39%. This discrepancy is a red flag, especially considering the potential risks associated with polypharmacy, where multiple psychotropic medications are prescribed simultaneously.
The report also draws attention to the over-prescription of Risperidone, a neuroleptic medicine, and Guanfacine, an ADHD medication, in CAMHS Area B compared to the national average. These medications are linked to side effects such as weight gain and sedation, which can significantly impact a child's well-being.
Unlicensed Medication Use: The Halpin Report reveals that Sodium Valproate, an anti-epileptic drug, was prescribed in 42% of cases to manage challenging behavior and sleep difficulties. Alarmingly, this medication is not licensed for treating behavioral issues or sleep problems in children with intellectual disabilities and is not typically used in CAMHS nationally.
Limited Therapeutic Options: Access to individual psychotherapy or 'talking therapies' was limited, and when available, patients faced lengthy waiting times. This is a critical issue, as psychotherapy is a cornerstone of mental health treatment, especially for children and adolescents.
The review identified inadequate physical health assessment and monitoring as the most common reason for potential harm. Many cases lacked essential cardiovascular monitoring, which is crucial when prescribing certain medications.
Impact on Vulnerable Populations: Children with intellectual disabilities and mental disorders faced a significant challenge, as they had no access to non-medical interventions. This is particularly concerning given that 46% of children attending the services had a confirmed or suspected autism diagnosis, and most of them were prescribed psychotropic medication.
Resource Shortfalls: The report underscores that the resources in CAMHS Area B Team were significantly below national mental health policy recommendations. This shortfall in resources likely contributed to the identified issues and highlights the need for robust governance and adequate funding to ensure safe and effective treatment for all patients.
Patient Referral Concerns: The report acknowledges the long wait times for families and the challenges they faced. It also reveals that during the review period, patients were frequently advised to self-refer to external services like Pieta House and Jigsaw for therapeutic support, despite the lack of formal agreements or governance arrangements with these agencies.
The review has been sent to the families of over 300 children who received treatment, and the HSE is expected to publish it later today. This review was prompted by an earlier audit that identified potential concerns in the care of 16 children, primarily related to prescribing practices and clinical concerns about a clinician's practice. The scale of the issues discovered has delayed the publication of the review, and early indications suggest that the findings for North Kerry CAMHS will be more critical than those of the South Kerry review, which identified serious harm in a significant number of cases.
This review raises critical questions about the standard of care and the potential risks faced by vulnerable children and adolescents. Are these isolated incidents, or do they point to systemic issues within the CAMHS system? What steps should be taken to ensure that such risks are mitigated in the future? Share your thoughts and join the conversation in the comments below.
